Prostate Cancer

Top Story

Autoimmune conditions, infections common among diffuse large B-cell lymphoma survivors

December 10, 2017

ATLANTA — Adults with diffuse large B-cell lymphoma had increased risk for developing autoimmune and infectious diseases within 10 years from diagnosis compared with breast and prostate cancer survivors, according to findings from a population-based study presented at the ASH Annual Meeting and Exposition.

Improved survival rates have led to an increasing number of DLBCL survivors, who may experience immune perturbations from treatment. Despite this, research on mid- and long-term immune health remains scarce.

Meeting News

Richard Pazdur, MD: FDA tasked with protection of patients, promotion of their concerns

December 7, 2017
SAN ANTONIO — Creating a dynamic regulatory environment requires the FDA is responsive to societal demands in conjunction with emerging scientific advances…

CDC, NCI launch public database with millions of cancer samples

December 1, 2017
The CDC has released a public-use research database that combines data from CDC’s National Program of Cancer Registries and NCI’s SEER program. It includes…
In the Journals

Less frequent biopsies needed for men with low-risk prostate cancer undergoing active surveillance

November 29, 2017
For men undergoing active surveillance for low-risk prostate cancer, biennial biopsies may be a viable alternative to annual biopsies, according to new research…
More Headlines »

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium


Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

There is no commercial support for this activity.

This CME case study will discuss the treatment of polycythemia rubra vera.
More »